Conferences

Harry Glorikian on Plenary Keynote Panel: Emerging Technologies & Industry Perspectives

Topic

Plenary Keynote Panel: Emerging Technologies & Industry Perspectives

The keynote program will feature a series of presentations on emerging and hot technologies in diagnostics, drug discovery & development, informatics, and oncology.

Panelists

• Harry Glorikian, Founder & Managing Partner, Scientia Advisors LLC
• Jeremy Bridge-Cook, Sr. VP of Assay Research and Development, Luminex Corporation
• Gary Kennedy, Chairman and CEO, Remedy MD
• Richard Lawn, Ph.D., Executive Director or Translational Medicine, SomoLogic
• Jeffrey T. Yap, Ph.D., Assistant Professor of Radiology, Harvard Medical School, Senior Diagnostic Physicist, Dana-Faber Cancer Institute

For more information, visit the Molecular Med Tri-Con 2012 Website